|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: PDXDC2P |
Gene summary for PDXDC2P |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | PDXDC2P | Gene ID | 109731405 |
| Gene name | pyridoxal dependent decarboxylase domain containing 2, pseudogene | |
| Gene Alias | PDXDC2 | |
| Cytomap | 16q22.1 | |
| Gene Type | pseudo | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 109731405 | PDXDC2P | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.96e-35 | 5.84e-01 | 0.294 |
| 109731405 | PDXDC2P | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 2.60e-16 | 1.29e+00 | 0.3487 |
| 109731405 | PDXDC2P | HTA11_99999965104_69814 | Human | Colorectum | MSS | 3.89e-44 | 1.15e+00 | 0.281 |
| 109731405 | PDXDC2P | HTA11_99999971662_82457 | Human | Colorectum | MSS | 6.97e-45 | 8.04e-01 | 0.3859 |
| 109731405 | PDXDC2P | HTA11_99999973899_84307 | Human | Colorectum | MSS | 9.03e-16 | 4.71e-01 | 0.2585 |
| 109731405 | PDXDC2P | HTA11_99999974143_84620 | Human | Colorectum | MSS | 6.20e-20 | 3.54e-01 | 0.3005 |
| 109731405 | PDXDC2P | HCC1 | Human | Liver | HCC | 3.12e-03 | 1.86e+00 | 0.5336 |
| 109731405 | PDXDC2P | HCC2 | Human | Liver | HCC | 7.17e-15 | 2.43e+00 | 0.5341 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Cervix | N_HPV |  |
| Endometrium | AEH |  |
| Endometrium | EEC |  |
| Prostate | BPH |  |
| Prostate | Tumor |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |